Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90.
Published February 12, 2020 · Recall initiated: January 24, 2020
Summary
FDA records drug Class II recall D-0828-2020, published February 12, 2020 and initiated January 24, 2020. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 192 Bottles; Lot: Lot #: 19122552, Exp 7/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
What to do
Voluntary: Firm initiated · Letter
Get an email if OLMESARTAN MEDOXOMIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OLMESARTAN MEDOXOMIL
- Manufacturer
- Ascend Laboratories LLC
- Distributor
- Nationwide in the U.S.
- UPC
- 0367877445304
- Lot
- Lot #: 19122552, Exp 7/31/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOlmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai,June 2, 2021
- FDAMinocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by:February 12, 2020
- FDAClonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem LaboratoriesFebruary 12, 2020
- FDAranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottlesFebruary 12, 2020
- FDADesmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc.February 12, 2020
- FDARanitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25February 12, 2020
Questions about this recall
Was Olmesartan Medoxomil Tablets 20 mg, Rx Only, 90 Tablets per Bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-446-90. recalled?
Yes. FDA published recall D-0828-2020 on February 12, 2020. Reported hazard: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OLMESARTAN MEDOXOMIL. UPC: 0367877445304.